Skip to main content
Watch Insiders
TLXSector not reported

Telix Pharmaceuticals Ltd (TLX) Insider Trading

In the last 90 days, 1 Telix Pharmaceuticals Ltd (TLX) insider reported 1 open-market purchase totaling $19,998 and no sales. The most recent open-market purchase was reported on Sep 7, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$19,998
Corporate buyers
1
Latest transaction
Sep 7, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 7, 2026Darren Charlton SmithGroup Chief Financial OfficerOpen Market Purchase2,071$9.66$19,998
Apr 29, 2026Christian BehrenbruchMD & Group CEOOpen Market Purchase67,935$14.67$996,736

Common questions

TLX insider trading FAQ

Are TLX insiders buying or selling?
Over the last 90 days, TLX insiders were net buyers, reporting $19,998 of open-market purchases and $0.00 of sales.
When was the last TLX insider purchase?
The most recent open-market purchase of Telix Pharmaceuticals Ltd stock by an insider was reported on Sep 7, 2026, one of 1 purchase in the last 90 days.
Where does TLX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Telix Pharmaceuticals Ltd officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.